ABT Molecular Imaging

ABT Molecular Imaging

ABT's technology produces doses of molecular imaging drugs for positron emission tomography (PET scanning) at the point of use.


Knoxville Company Successfully Achieves Commercial Use of its Next-Generation Biomarker Generator

ABT Molecular Imaging, Inc., in Knoxville, TN, has successfully achieved the installation and clinical use of its next-generation Biomarker Generator by the Sveta Marina University Hospital in Bulgaria. ABT’s next-generation product integrates a compact accelerator and micro-chemistry with integrated quality control, for single-dose biomarker production.

ABT Bags $6 Mil

ABT Molecular Imaging, a medical imaging company, has raised $6 million from River Cities Capital (which led the round), Mountain Group Capital, and Intersouth Partners. Rik Vandevenne of River Cities will join the company’s board.




River Cities Fund IV

Year Invested


City and State

Knoxville, TN

Portfolio Manager

Rik Vandevenne